Multiphasic 68Ga-PSMA PET/CT in the detection of early recurrence in prostate cancer patients with a PSA level of less than 1 ng/mL: a prospective study of 135 …

M Beheshti, R Manafi-Farid, H Geinitz… - Journal of Nuclear …, 2020 - Soc Nuclear Med
The main objective of this prospective study was to determine the impact of multiphasic
acquisition of 68Ga-PSMA PET/CT in the detection of recurrent prostate cancer in the early …

68Ga-PSMA-11 PET/CT in primary and recurrent prostate carcinoma: implications for radiotherapeutic management in 121 patients

SA Koerber, L Will, C Kratochwil… - Journal of Nuclear …, 2019 - Soc Nuclear Med
The present study analyzed the impact of 68Ga-labeled prostate-specific membrane antigen-
HBED-CC (68Ga-PSMA-11) PET/CT on radiotherapeutic management in a large cohort of …

Detection rate and localization of prostate cancer recurrence using 68Ga-PSMA-11 PET/MRI in patients with low PSA values≤ 0.5 ng/mL

B Kranzbühler, J Müller, AS Becker… - Journal of Nuclear …, 2020 - Soc Nuclear Med
A first analysis of simultaneous 68Ga-prostate-specific membrane antigen (PSMA)-11
PET/MRI showed some improvement in the detection of recurrent disease at low serum …

Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer

Y Sanli, S Kuyumcu, O Sanli, F Buyukkaya… - Annals of nuclear …, 2017 - Springer
Aim To investigate the relationship between serum PSA level, Gleason score of PCa and the
outcomes of Ga 68-PSMA PET/CT in patients with recurrent PCa. Methods A total of 109 …

Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score

FA Verburg, D Pfister, A Heidenreich, A Vogg… - European journal of …, 2016 - Springer
Purpose To examine the relationship between the extent of disease determined by [68 Ga]
PSMA-HBED-CC-PET/CT and the important clinical measures prostate-specific antigen …

68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT

C Bluemel, M Krebs, B Polat, F Linke… - Clinical nuclear …, 2016 - journals.lww.com
Purpose Investigating the value of 68 Ga-PSMA-PET/CT in biochemically recurring prostate
cancer patients with negative 18 F-choline-PET/CT. Patients and Methods One hundred …

Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific …

S Schmuck, S Nordlohne, CA von Klot… - European journal of …, 2017 - Springer
Purpose The aim of this study was to assess the value of dual-time point imaging in PET/CT
for detection of biochemically recurrent or persistent prostate cancer, using the prostate …

The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels

L Kabasakal, E Demirci, J Nematyazar… - Nuclear Medicine …, 2017 - journals.lww.com
Results Patients had an average PSA of 1.41 ng/ml. A total of 29 patients (58%) showed at
least one positive lesion. PET positivity rates of 31%(n= 4), 54%(n= 13), and 88%(n= 14) …

68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

F Ceci, C Uprimny, B Nilica, L Geraldo… - European journal of …, 2015 - Springer
Purpose To assess the association between PSA levels, PSA kinetics and other factors and
a pathological 68 Ga-PSMA PET/CT scan in patients with recurrent prostate cancer (rPCa) …

Early PET imaging with [68] Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence

C Uprimny, AS Kroiss, J Fritz, C Decristoforo… - European Journal of …, 2017 - Springer
Abstract Purpose PET/CT using 68 Ga-labelled prostate-specific membrane antigen PSMA-
11 (HBEDD-CC) has emerged as a promising imaging method in the diagnostic evaluation …